Nick joined the Ananda Group in February 2023 and is responsible for overseeing the Group’s clinical trials, drug development, manufacturing and research through Ananda subsidiary, MRX Medical. Prior to joining the Group, Nick founded PhytoVista laboratories in 2016, which went on to become a leading UKAS accredited laboratory that provided analytical services for manufacturers of consumer CBD products, as well as Cannabis Based Products for Medicinal use. He also spent 7 years at AstraZeneca, where he worked in medicines development across candidate drug discovery up to phase III clinical trials.

Nick also has experience outside of the pharmaceutical industry, having started his career with a scholarship at Zeneca Agrochemicals working as a soil scientist, before moving to a position in the food industry looking at authenticity and adulteration in foods and drinks. He holds a BSc in Applied Chemistry and is passionate about supporting MRX Medical and the Group to achieve its goal of producing robust clinical evidence and wider prescription of cannabinoid medicines in areas of unmet clinical need.